Anti-CD20 Antibody (Ofatumumab)
Catalog No.
F1173
Anti-CD20 Antibody (Ofatumumab)
Featured Products
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.94 kDa
Dry ice
679818-59-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Arzerra, Kesimpta, GSK1841157
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P11836
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Romas cells were stained with Anti-CD20 Antibody (Ofatumumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
CD20
Please avoid freeze-thaw cycles.